Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX 27 EV-to-EBIT is 19.78 as of Jul. 25, 2026. GuruFocus rates ASX:CSX with a GF Score™ of 27/100 and a GF Value™ of A$0.55 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 465 Medical Devices & Instruments companies, CleanSpace Holdings ranks worse than 54.41% on this metric.
The historical rank and industry rank for CleanSpace Holdings's EV-to-EBIT or its related term are showing as below:
ASX:CSX'
s EV-to-EBIT Range Over the Past 10 Years
Min: -62.64 Med: -1.6 Max: 19.77
Current: 19.77
During the past 6 years, the highest EV-to-EBIT of CleanSpace Holdings was 19.77. The lowest was -62.64. And the median was -1.60.
ASX:CSX's EV-to-EBIT is ranked worse than 54.41% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 18.19
vs ASX:CSX: 19.77
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
CleanSpace Holdings's Enterprise Value for the quarter that ended in Dec. 2025 was A$45.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CleanSpace Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CleanSpace Holdings EV-to-EBIT Related Terms
CleanSpace Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for CleanSpace Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CleanSpace Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's EV-to-EBIT falls into.
CleanSpace Holdings's current Enterprise Value is A$24.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CleanSpace Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CleanSpace Holdings (ASX:CSX) has a EV-to-EBIT of 19.78 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CleanSpace Holdings and its competitors. According to the industry distribution chart, CleanSpace Holdings ranks #253 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 54.4%.
Is CleanSpace Holdings' EV-to-EBIT too high?
CleanSpace Holdings' current EV-to-EBIT is 19.78. The Medical Devices & Instruments industry median EV-to-EBIT is 18.19. CleanSpace Holdings' value of 19.78 is 8.7% above this industry median. Based on the distribution chart, CleanSpace Holdings ranks #253 out of 465 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CleanSpace Holdings has a GF Score™ of 27/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #253 out of 465 companies for EV-to-EBIT. This places CleanSpace Holdings in the lower half of its industry. The industry median EV-to-EBIT is 18.19. CleanSpace Holdings' value of 19.78 is 8.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.19, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CleanSpace Holdings's current EV-to-EBIT of 19.78 is 8.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CleanSpace Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CleanSpace Holdings's current EV-to-EBIT is 19.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.55, compared to a current price of A$0.40 — trading 28.2% below its estimated fair value. The current EV-to-EBIT is 19.78 and 8.7% above the Medical Devices & Instruments industry median of 18.19. CleanSpace Holdings' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current EV-to-EBIT is 19.78 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.40 is trading 28.2% below its estimated GF Value™ of A$0.55.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
EV-to-EBIT: 19.78
GF Value™: A$0.55 vs. price of A$0.40 (28.2% below fair value)
Industry Position: 8.7% above the Medical Devices & Instruments median (#253 of 465)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
27GF Score
Get the complete analysis for ASX:CSX
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
